ArticleBreast cancer (Dove Medical Press)2021

Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis.

Ami Vyas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.